Antibiotics Use Patterns in Low- and Middle-Income Countries: A Systematic Review Analysis
Abstract
Antibiotics are vital for treating infections, but their inappropriate use has driven widespread resistance, now a major global health threat. This systematic review examines antibiotic use patterns in low- and middle-income countries using WHO's prescribing indicator, aiming to guide interventions that promote rational antibiotic use, reduce resistance, and improve public health outcomes. The review followed PRISMA guidelines, searching databases such as Scopus, Embase (Ovid), and Medline (Ovid) for publications from January 2010 to November 2025. Titles and abstracts were initially screened by the first reviewer and discussed with a second reviewer to assess eligibility. Full texts of eligible articles were then independently reviewed by the reviewers, with final inclusion determined through consensus. The methodological quality of selected studies was evaluated using the Kmet Critical Appraisal Checklist. Studies were categorized into 3 groups-public and private sector, public sector only, and private sector only-to examine antibiotic use patterns relative to WHO standards, alongside demographic and institutional data. Electronic searches identified 2912 studies, of which 20 cross-sectional studies were from 11 countries considered eligible for inclusion. Their methodological quality scores ranged from 0.50 to 0.78. Across all studies, the average "percentage of prescriptions with antibiotics" was 51.4%, with 52.7% in the private sector, 49.3% in the public sector, and…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.